Stay updated on CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial page.

Latest updates to the CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial page
- Check2 days agoChange DetectedThe page footer “Revision” number was updated from v3.5.2 to v3.5.3, indicating a platform/version update without changing the underlying study information.SummaryDifference0.1%

- Check9 days agoChange DetectedAdded: Cabozantinib Versus Sunitinib... CABOSUN Trial publication (Choueiri et al., J Clin Oncol 2017) with erratum and subsequent updates (v3.5.2). Deleted: the earlier CABOSUN JCO 2017 entry (v3.5.0).SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check39 days agoChange DetectedRevision: v3.5.0 added; Revision: v3.4.3 removed.SummaryDifference0.1%

- Check46 days agoChange DetectedFooter revision label updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check75 days agoChange DetectedAdded Revision: v3.4.2 to the page. Removed the previous Revision: v3.4.1 text and the government funding operating-status notice.SummaryDifference0.5%

- Check82 days agoChange DetectedA government funding lapse notice was added at the top of the page, informing users that information may not be up to date and directing to cc.nih.gov and opm.gov. The site revision version now shows v3.4.1, replacing v3.4.0.SummaryDifference0.5%

Stay in the know with updates to CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial page.